A detailed history of Frank, Rimerman Advisors LLC transactions in Haleon PLC stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 20,457 shares of HLN stock, worth $199,251. This represents 0.02% of its overall portfolio holdings.

Number of Shares
20,457
Previous 38,061 46.25%
Holding current value
$199,251
Previous $314,000 31.21%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$8.32 - $10.7 $146,465 - $188,362
-17,604 Reduced 46.25%
20,457 $216,000
Q2 2024

Aug 13, 2024

BUY
$8.01 - $8.64 $304,868 - $328,847
38,061 New
38,061 $314,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $45B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.